85 FR 152 pg. 47793 - Notice of Meeting
Type: NOTICEVolume: 85Number: 152Page: 47793
Page: 47793FR document: [FR Doc. 2020-17224 Filed 8-5-20; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Agency for Healthcare Research and Quality
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY:
Agency for Healthcare Research and Quality, HHS.
ACTION:
Notice.
SUMMARY:
The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on "HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-ZHS1 HSR-F (01)." This SEP meeting will be closed to the public.
DATES:
August 26, 2020.
ADDRESSES:
Agency for Healthcare Research and Quality (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20850, Telephone: (301)427-1557.
SUPPLEMENTARY INFORMATION:
A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly-scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.
The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the "HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-ZHS1 HSR-F (01)" is to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities dictate.
Dated: August 3, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-17224 Filed 8-5-20; 8:45 am]
BILLING CODE 4160-90-P